✦ LIBER ✦

9411 The novel HSP90 inhibitor NVP-AUY922 demonstrates activity in rhabdomyosarcoma cell lines

✍ Scribed by Slater, O.; Renshaw, J.; Workman, P.; Pritchard-Jones, K.

Book ID: 123085033
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 44 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71999-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Signalling profile and antitumour activi

Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma

✍ Stühmer, T; Zöllinger, A; Siegmund, D; Chatterjee, M; Grella, E; Knop, S; Kortüm 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 360 KB

Synergistic action of the novel HSP90 in

Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma

✍ Martin Kaiser; Britta Lamottke; Maren Mieth; Michael R. Jensen; Cornelia Quadt; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

Antitumor activity of NVP-AUY922, a nove

Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins

✍ Kyung-Hun Lee; Ju-Hee Lee; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Do-Youn Oh; Yu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

233 THE INFLUENCE OF THE HEAT SHOCK PROT

233 THE INFLUENCE OF THE HEAT SHOCK PROTEIN 90 (HSP90) INHIBITOR, NVP-AUY922, AND HYPOXIA ON THE EXPRESSION OF HIF-1α AND HIF-2α IN TWO HEAD AND NECK CANCER CELL LINES

✍ C. Bayer; D. Schilling; G. Multhoff 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

The novel HSP90 inhibitor STA-1474 exhib

The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines

✍ Jennifer K. McCleese; Misty D. Bear; Stacey L. Fossey; Robert M. Mihalek; Kevin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 568 KB

## Abstract Osteosarcoma (OSA), the most common malignant bone tumor in dogs and children, exhibits a similar clinical presentation and molecular biology in both species. Unfortunately, 30–40% of children and 90% of dogs still die of disease despite aggressive therapy. The purpose of this study was

Increased radiosensitivity and radiother

Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990

✍ Dušan Milanović, Elke Firat, Anca Ligia Grosu, Gabriele Niedermann 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 273 KB